Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels

American Journal of Gastroenterology

Volumn 92, Issue 10, 1997, Pages 1793-1795

  Silverman, Ann L ^a   Piquette, Deborah L ^a   Filipiak, Charles L ^a   Neill, James S ^a   Bayati, Nasser ^a   Gordon, Stuart C ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA INTERFERON;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ENZYME TESTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; RNA, VIRAL; VIREMIA;

EID: 0030767251     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321:1501-6.
2. DiBisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989;321: 1506-10.
3. Stevens CE, Taylor PE, Pindyck J, et al. Epidemiology of hepatitis C virus. JAMA 1990;263:49-53.
4. Naito M, Hayashi N, Hagiwara H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C carriers with persistently normal ALT levels. Hepatology 1994;19:871-5.
5. Shakil AO, Conry-Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic and histologic features. Ann Intern Med 1995;123:330-7.
6. Bayati N, Nadir A, Sekhon JS, et al. Demographic features and clinical outcomes in hepatitis C. Gastroenterology 1997;112:A1223.
7. Silverman AL, McCray DG, Gordon SC, et al. Experimental evidence against replication of or dissemination of hepatitis C virus in mosquitoes (Diptera: Culicidae) using detection by reverse transcriptase polymerase chain reaction. J Med Entomol 1996;33:398-401.
8. Damen M, Cuypers HT, Zaaijer HL, et al. International collaborative study on the second Eurohep HCV-RNA reference panel. J Virol Methods 1996;58:175-85.
9. Farci P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
10. Serfaty L, Chazouilleres O, Pawlotsky J-M, et al. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-5.
11. Gholson CF, Favrot D, Taylor B, et al. Chronic hepatitis C virus (HCV) infection and persistently normal aminotransferases (PNAL): A preliminary report of alfa interferon (IFN) resistance. Hepatology 1996;24:401A.
12. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
13. Tietz NW, ed. Clinical guide to laboratory tests, 3rd ed. Philadelphia: WB Saunders Company, 1995:20.
14. Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med 1995;332:1463-6.
15. Gordon SC, Elloway RS, Long JC, et al. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. intravenous drug use. Hepatology 1993;18:1338-43.